Clinical Trial Update: PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pirtobrutinib as frontline therapy for elderly unfit/frail mantle cell lymphoma; trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Pirtobrutinib (pirtobrutinib)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING